. 2015 Oct 29;37(21):1659–1666. doi: 10.1093/eurheartj/ehv559

Table 2.

Cell characteristics

	Single treatment	Repeated treatment		P value (single vs. first repeated)	P value (first vs. second Tx)
	(n = 186) Median (IQR)	First Tx (n = 111) Median (IQR)	Second Tx (n = 111) Median (IQR)	P value (single vs. first repeated)	P value (first vs. second Tx)
Cell number (×10⁶ mononuclear cells)	168 (109–254)	151 (93–240)	123 (80–200)	0.20	0.07
SDF-1-induced migration capacity	90 (59–146)	97 (61–142)	104 (65–155)	0.72	0.61
Colony-forming unit capacity	23 (16–38)	20 (14–32)	20 (13–28)	0.02	0.29
CD45⁺CD34⁺ cells (%) (assay 1^a, n = 181)	2.1 (1.2–2.9) (n = 114)	1.8 (0.8–2.5) (n = 44)	2.0 (0.9–3.1) (n = 23)	0.34	0.92
CD45⁺CD34⁺ cells (%) (assay 2^a, n = 220)	1.3 (1.1–1.8) (n = 65)	1.3 (1.0–1.8) (n = 67)	1.4 (1.0–2.0) (n = 88)	0.99	0.90

^aThe FACS protocol and antibodies were changed during the ongoing registry.